Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.
The company today priced its public offering of 4,054,055 shares at $18.50 per share.
Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.
RAPT has traded in the range of $9.85- $40.74 in the last 1 year.
Source: Read Full Article
Lates News:
-
The Perfect Imperfection: Unpacking Michael Saylor’s Bitcoin Assertion
-
Bitcoin Mining Powered by Excess Energy: Lugano's Sustainable Initiative
-
Greenpeace Says Bitcoin Is ‘Defiantly Refusing To Accept Its Climate Responsibility’
-
$BTC Recent Sell-off 'Almost Exclusively' Carried out by Short-Term Holders, Says Coinbase Research
-
Bitcoin (BTC) Supply on Exchanges Drops to 6-Year Low as Tether Whales Eye Market Entry